The first doses of a breakthrough treatment have been delivered to patients with chronic lymphocytic leukemia in Armenia and Nepal! – The Max Foundation
The Max Foundation made the following post on LinkedIn:
“We have some amazing news today!
Thanks to our collaboration with BeiGene, a global oncology company, and the BeiGene Foundation, a nonprofit charitable foundation, the first doses of a breakthrough treatment have been delivered to patients with chronic lymphocytic leukemia (CLL) in Armenia and Nepal!
We hope to provide access to the treatment in 29 low- and middle-income countries over the next few years.
This is a huge milestone for our mission to accelerate health equity and provide access to the best possible care for people living with cancer. We’re grateful to BeiGene and the BeiGene Foundation for sharing our commitment and generosity!”
Read further.
Source: The Max Foundation/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023